Reader Comments (47)
Post a new comment on this article
-
4 Responses22 Jul 2013
16:22 GMT
Most RecentMedia Coverage of This Article Posted by PLOS_ONE_Group on 21 Oct 2011 at 18:59 GMT -
1 Response04 Mar 2013
10:20 GMT
Most RecentIn search of the autoantibody, or biomarker... Posted by Maddison on 04 Nov 2011 at 11:58 GMT -
5 Responses23 Feb 2012
01:49 GMT
Most RecentWas the blinding in this study effective? Posted by WensaasKA on 09 Feb 2012 at 06:54 GMT -
0 Responses08 Jan 2012
01:20 GMT
Most RecentDid the researchers have the opportunity to look at viral antibodies? Posted by Jacquelineerose on 08 Jan 2012 at 01:20 GMT -
6 Responses16 Dec 2011
21:15 GMT
Most RecentCould the authors give the raw (non-normalized) SF-36 subscale scores Posted by tkindlon on 05 Nov 2011 at 14:49 GMT -
2 Responses21 Nov 2011
16:06 GMT
Most RecentRemember the two major problems with this study Posted by matsreimer on 16 Nov 2011 at 20:44 GMT -
0 Responses05 Nov 2011
17:52 GMT
Most RecentThank you from a severe M.E. patient Posted by half-life on 05 Nov 2011 at 17:52 GMT -
16 Responses04 Nov 2011
17:13 GMT
Most RecentRituximab in CFS; more research needed Posted by jvandermeer on 27 Oct 2011 at 07:36 GMT -
2 Responses31 Oct 2011
17:37 GMT
Most RecentRituximab-driven Improvement of CFS Symptoms: Suppression of Autoantibody-mediated Autoimmunity or Enhanced Cell-mediated Immunity Following B Cell Depletion? Posted by Pawel on 25 Oct 2011 at 14:04 GMT -
0 Responses29 Oct 2011
21:28 GMT
Most RecentEncouragement to monitor glutathione in RTX studies Posted by richvank on 29 Oct 2011 at 21:28 GMT -
0 Responses20 Oct 2011
05:48 GMT
Most RecentTime for a high quality autoantibody profiling study. Posted by Architectonic on 20 Oct 2011 at 05:48 GMT